ENPAC: phase II trial with safety lead of enzalutamide in combination with paclitaxel and carboplatin for advanced or recurrent endometrioid endometrial adenocarcinoma
暂无分享,去创建一个
A. Jazaeri | Ying Yuan | K. Lu | B. Fellman | S. Westin | P. Ramirez | M. Frumovitz | N. Fleming | A. Shafer | L. Meyer | P. Soliman | R. Coleman | L. Cobb | Jolyn S. Taylor | Gordon Mills | T. Alvarado | Sara Hull